相关实验视频

Updated: Jan 15, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

13.9K

严重的肝功能障碍和扩散性肝转移中的表现不佳的跨动脉输液化疗:一个病例报告

Xiao-Chun Chen1, Xian-Qin Li1, Yi Liu1

  • 1Department of Oncology, The First People's Hospital of Yibin, Yibin, Sichuan 644000, P.R. China.

Oncology letters
|October 13, 2025
PubMed
概括

通过静脉输液的化学疗法 (TAI) 使用降低剂量的埃托和西斯普拉丁为晚期前列腺神经内分泌癌,严重肝功能障碍和表现不佳状态 (PS) 提供了可行的治疗选择. 这种方法可能会延长超出息护理预期的生存期.

关键词:
孩子-Pugh 的孩子-Pugh.扩散性肝转移的发生.肝动脉输液输注 肝动脉输注绩效状态的表现情况.前列腺神经内分泌癌瘤前列腺神经内分泌癌瘤

更多相关视频

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver09:02

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver

Published on: July 31, 2016

12.3K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.1K

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
212